Annual Operating Expenses
$94.31 M
+$19.72 M+26.44%
December 31, 2024
Summary
- As of March 12, 2025, AVBP annual total operating expenses is $94.31 million, with the most recent change of +$19.72 million (+26.44%) on December 31, 2024.
- AVBP annual operating expenses is now at all-time high.
Performance
AVBP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$23.70 M
-$527.00 K-2.17%
December 31, 2024
Summary
- As of March 12, 2025, AVBP quarterly total operating expenses is $23.70 million, with the most recent change of -$527.00 thousand (-2.17%) on December 31, 2024.
- Over the past year, AVBP quarterly operating expenses has dropped by -$1.99 million (-7.75%).
- AVBP quarterly operating expenses is now -7.75% below its all-time high of $25.70 million, reached on June 30, 2024.
Performance
AVBP Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AVBP Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.4% | -7.8% |
| 3 y3 years | - | -7.8% |
| 5 y5 years | - | -7.8% |
AVBP Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +155.5% | -7.8% | +127.0% |
| 5 y | 5-year | at high | +155.5% | -7.8% | +127.0% |
| alltime | all time | at high | +155.5% | -7.8% | +127.0% |
ArriVent BioPharma Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $94.31 M(+26.4%) | $23.70 M(-2.2%) |
| Sep 2024 | - | $24.23 M(-5.7%) |
| Jun 2024 | - | $25.70 M(+24.3%) |
| Mar 2024 | - | $20.67 M(-10.6%) |
| Dec 2023 | $74.59 M | $23.12 M(+38.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $16.72 M(-26.0%) |
| Jun 2023 | - | $22.58 M(+85.5%) |
| Mar 2023 | - | $12.17 M(+16.6%) |
| Dec 2022 | $36.91 M | - |
| Dec 2022 | - | $10.44 M(-11.3%) |
| Sep 2022 | - | $11.77 M |
FAQ
- What is ArriVent BioPharma annual total operating expenses?
- What is the all time high annual operating expenses for ArriVent BioPharma?
- What is ArriVent BioPharma annual operating expenses year-on-year change?
- What is ArriVent BioPharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for ArriVent BioPharma?
- What is ArriVent BioPharma quarterly operating expenses year-on-year change?
What is ArriVent BioPharma annual total operating expenses?
The current annual operating expenses of AVBP is $94.31 M
What is the all time high annual operating expenses for ArriVent BioPharma?
ArriVent BioPharma all-time high annual total operating expenses is $94.31 M
What is ArriVent BioPharma annual operating expenses year-on-year change?
Over the past year, AVBP annual total operating expenses has changed by +$19.72 M (+26.44%)
What is ArriVent BioPharma quarterly total operating expenses?
The current quarterly operating expenses of AVBP is $23.70 M
What is the all time high quarterly operating expenses for ArriVent BioPharma?
ArriVent BioPharma all-time high quarterly total operating expenses is $25.70 M
What is ArriVent BioPharma quarterly operating expenses year-on-year change?
Over the past year, AVBP quarterly total operating expenses has changed by -$1.99 M (-7.75%)